The contribution of pharmacokinetic–pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis
- 1 January 2007
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 13 (1) , 33-39
- https://doi.org/10.1111/j.1469-0691.2006.01617.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Susceptibility of Neisseria meningitidis to 16 Antimicrobial Agents and Characterization of Resistance Mechanisms Affecting Some AgentsJournal of Clinical Microbiology, 2005
- How Contagious Are Common Respiratory Tract Infections?New England Journal of Medicine, 2003
- Pharmacokinetics of intravenous azithromycin and ceftriaxone when administered alone and concurrently to healthy volunteersJournal of Antimicrobial Chemotherapy, 2002
- Meningococcal DiseaseNew England Journal of Medicine, 2001
- Pathophysiology, Treatment and Outcome of Meningococcemia: A Review and Recent ExperienceThe Pediatric Infectious Disease Journal, 1996
- Evidence for a Slow Elimination Phase for Penicillin GThe Journal of Infectious Diseases, 1988
- Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactamAntimicrobial Agents and Chemotherapy, 1983
- Pharmacokinetics of intravenous chloramphenicol sodium succinate in adult patients with normal renal and hepatic functionJournal of Pharmacokinetics and Biopharmaceutics, 1982
- Pharmacokinetics of Tetracycline in Nutritional OedemaChemotherapy, 1982
- Complications and sequelae of meningococcalinfections in childrenThe Journal of Pediatrics, 1981